MAGEA9 anticorps (N-Term)
Aperçu rapide pour MAGEA9 anticorps (N-Term) (ABIN925904)
Antigène
Voir toutes MAGEA9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Immunogène
- MAGEA9 antibody was raised in rabbit using the N terminal of MAGEA9 as the immunogen
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MAGEA9 Blocking Peptide, (ABIN5614633), is also available for use as a blocking control in assays to test for specificity of this MAGEA9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAGEA9 (Melanoma Antigen Family A, 9 (MAGEA9))
-
Autre désignation
- MAGEA9
-
Sujet
- This pseudogene is a member of the cytochrome P450 gene superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine. This locus is part of a cluster of cytochrome P450 genes on chromosome 22q13.1. Synonyms: Polyclonal MAGEA9 antibody, Anti-MAGEA9 antibody, melanoma antigen family A, 9 antibody.
Antigène
-